Подписаться
T A Wilkins
T A Wilkins
Professor of Nanotechnology, Leeds University
Подтвержден адрес электронной почты в домене leeds.ac.uk
Название
Процитировано
Процитировано
Год
Collaborative diversity in a nanotechnology innovation system: Evidence from the EU Framework Programme
K Pandza, T Wilkins, E Alfoldi
Technovation 31, 476–489, 2011
1082011
Nano (Q) SAR: Challenges, pitfalls and perspectives
R Tantra, C Oksel, T Puzyn, J Wang, KN Robinson, XZ Wang, CY Ma, ...
Nanotoxicology 9 (5), 636-642, 2015
892015
Characterization of Nanoparticle Batch-To-Batch Variability
S Mülhopt, T Diabaté, Silvia, Wilkins, et al
Nanomaterials 8 (5), 1-24, 2018
832018
Characterization of Nanoparticle Batch-To-Batch Variability
S Mulhopt, T Diabate, Silvia, Wilkins
Nanomaterials DOI: 10.3390/nano8050311 8 (311), 24, 2018
832018
(Q)SAR modelling of nanomaterial toxicity: A critical review
C Oksel, CY Ma, JJ Liu, T Wilkins, XZ Wang
Particuology 21, 1-19, 2015
722015
Sensitive test for thyroid hormone autoantibodies in serum
DJ Allan, F Murphy, CA Needham, N Barron, TA Wilkins, JEM Midgley
The Lancet 320 (8302), 824, 1982
681982
Comprehensive study of a thyroxin-analog-based assay for free thyroxin (" Amerlex FT4").
TA Wilkins, JE Midgley, Barron, N
Clinical chemistry 31 (10), 1644-1653, 1985
601985
A comparison of free T4, and the ratio of total T4 to T4-binding globulin in serum through pregnancy
AS Whitworth, JEM Midgley, TA Wilkins
Clinical Endocrinology 17, 307-313, 1982
471982
Electrochemical and morphological investigation of silver and zinc modified calcium phosphate bioceramic coatings on metallic implant materials
M Furko, Y Jiang, TA Wilkins, C Balázsi
Materials Science and Engineering: C 62, 249-259, 2016
442016
Accurate and interpretable nanoSAR models from genetic programming-based decision tree construction approaches
C Oksel, DA Winkler, CY Ma, T Wilkins, XZ Wang
Nanotoxicology 10 (7), 1001-1012, 2016
432016
New methods of free thyroid hormone assay
TA Wilkins, JEM Midgley
Bizollon, Ch.A. (ed.); 370 p; ISBN 0-444-80358-0; Worldcat; 1981; p. 215-234 …, 1981
421981
Understanding the role and impact of poly (ethylene glycol)(PEG) on nanoparticle formulation: Implications for COVID-19 vaccines
E Padín-González, P Lancaster, M Bottini, P Gasco, L Tran, B Fadeel, ...
Frontiers in bioengineering and biotechnology 10, 882363, 2022
402022
The direct estimation of free hormones by a simple equilibrium radioimmunoassay
JEM Midgley, TA Wilkins
Amersham: Radiochemical Centre, 1981
401981
EMERGNANO: A review of completed and near completed environment, health and safety research on nanomaterials and nanotechnology
RJ Aitken, SM Hankin, B Ross, CL Tran, V Stone, TF Fernandes, ...
Defra Project CB0409. Edinburgh, UK, Institute of Occupational Medicine, 2009
392009
Application of isothermal titration calorimetry in evaluation of protein–nanoparticle interactions
E Omanovic-Miklicanin, I Manfield, T Wilkins
Journal of Thermal Analysis and Calorimetry 127, 605-613, 2017
352017
Validity of analog free thyroxin immunoassays. Part II.
JE Midgley, CR Moon, TA Wilkins
Clinical chemistry 33 (12), 2145-2152, 1987
321987
Treatment with heparin and results for free thyroxin: an in vivo or an in vitro effect?
TA Wilkins, JE Midgley, AF Giles
Clinical chemistry 28 (12), 2441-2443, 1982
321982
Risk Management Framework for Nano-Biomaterials Used in Medical Devices and Advanced Therapy Medicinal Products
E Giubilato
Materials 13 (20), 4532, 2020
312020
Derivatives of iodothyronine compounds and their use in an assay for the free iodothyronine compounds
GM Cree, TA Wilkins, R Monks, DP Nowotnik
US Patent 4,426,453, 1984
311984
Assay for the free portion of substances in biological fluids
JE Midgley, TA Wilkins
US Patent 4,366,143, 1982
281982
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20